Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/21/2002 | WO2002022843A2 Nucleotide sequences which code for the dep34 gene |
03/21/2002 | WO2002022831A1 Thermotolerant ribonuclease h |
03/21/2002 | WO2002022829A2 Nucleotide sequences which code for the ppsa gene |
03/21/2002 | WO2002022827A1 Isolation and sequences of the ptsi gene of c. glutamicum |
03/21/2002 | WO2002022825A2 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
03/21/2002 | WO2002022824A2 Ashbya gossypii genes coding for proteins involved in membrane transport |
03/21/2002 | WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
03/21/2002 | WO2002022812A1 Methods of assaying or screening compound via detection of nuclear transport receptor inhibition by hepatitis c virus core protein |
03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
03/21/2002 | WO2002022802A1 Novel compounds |
03/21/2002 | WO2002022799A2 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
03/21/2002 | WO2002022785A1 Improvements in or relating to selective agents for biological cultures |
03/21/2002 | WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
03/21/2002 | WO2002022779A2 High level expression of heterologous proteins |
03/21/2002 | WO2002022687A2 Viral chemokine-tumur antigen fusion proteins |
03/21/2002 | WO2002022686A2 Defensin-antigen fusion proteins |
03/21/2002 | WO2002022684A2 Transporters and ion channels |
03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/21/2002 | WO2002022673A2 Proteins participating in nucleotide metabolism and genes coding for the same from ashbya gossypii |
03/21/2002 | WO2002022672A1 Nucleotide sequences coding for the ccsb gene |
03/21/2002 | WO2002022671A1 Nucleotide sequences coding for the pstc2 gene |
03/21/2002 | WO2002022670A1 Nucleotide sequences coding for the ftsx gene |
03/21/2002 | WO2002022668A1 Nucleotide sequences which code for the roda gene |
03/21/2002 | WO2002022667A2 Twin-arginine translocation in bacillus |
03/21/2002 | WO2002022638A1 22 human secreted proteins |
03/21/2002 | WO2002022633A2 Nucleotide sequences which code for the atr61 gene |
03/21/2002 | WO2002022632A2 Nucleotide sequences coding for the pknd gene |
03/21/2002 | WO2002000706A3 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
03/21/2002 | WO2001094569A3 Corynebacterium glutamicum nucleotide sequences coding for the glbo gene |
03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
03/21/2002 | WO2001077159A3 An endogenous ketogulonigenium plasmid |
03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
03/21/2002 | WO2001068854A3 Fibroblast growth factor-like molecules and uses thereof |
03/21/2002 | WO2001068818A3 Hcv ns2/3 fragments and uses thereof |
03/21/2002 | WO2001064919A3 18036, a novel calpain-like protease and uses thereof |
03/21/2002 | WO2001064837A3 β NETRIN AND USES THEREOF |
03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
03/21/2002 | WO2001062066A3 For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture |
03/21/2002 | WO2001060991A3 Human kinases |
03/21/2002 | WO2001055411A3 Human sulfatases |
03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
03/21/2002 | WO2001051510A3 G-csf conjugates |
03/21/2002 | WO2001047952A3 Insecticidal proteins from bacillus thuringiensis |
03/21/2002 | WO2001032712A3 Antibody diversity generation |
03/21/2002 | WO2001031009A3 Chandra: a th1-specific gene |
03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
03/21/2002 | WO2000073412A3 Apparatus and method for analyzing a fluid sample |
03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
03/21/2002 | US20020035249 Production of exopolysaccharides unattached to the surface of bacterial cells |
03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
03/21/2002 | US20020035245 Recombinant vanadium haloperoxidases and their uses |
03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
03/21/2002 | US20020034816 Genetically engineered gram-positive bacterium for the generation of ethyl alcohol |
03/21/2002 | US20020034815 Method of improving biomass yield of lactic acid bacterial cultures |
03/21/2002 | US20020034812 Caspase homologue |
03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
03/21/2002 | US20020034794 Nucleotide sequences which encode the gpsA gene |
03/21/2002 | US20020034793 L-arginine producing escherichia coli and method of producing L-arginine |
03/21/2002 | US20020034790 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
03/21/2002 | US20020034788 Improving dicarboxylic acid production in yeast by replacing the native promoter of a target gene with a heterologous promoter from a yeast gene having a desired level of activity |
03/21/2002 | US20020034779 Novel argS |
03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
03/21/2002 | US20020034776 Genetically engineering enzymatic proteins; transform eschericha, generate mutations, transmit mutation to another microoganism and detect enzymatic activity, recover microorganism with adjusted enzymatic activity |
03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
03/21/2002 | US20020034523 Immunogenic preparation and method for improving the productivity of ruminant animals |
03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
03/21/2002 | US20020034515 Proteus mirabilis-based vaccine |
03/21/2002 | US20020034497 Biological control of purple loosestrife |
03/21/2002 | US20020033366 Method for water denitrification |
03/21/2002 | US20020032981 Clustered creature exterminating method |
03/21/2002 | DE10136987A1 Für das clpC-Gen kodierende Nukleotidsequenzen For the CLPC gene coding nucleotide sequences |
03/21/2002 | DE10136986A1 New cysD, N, K, E and H genes from coryneform bacteria, useful, when over expressed, for increasing fermentative production of L-amino acids |
03/21/2002 | DE10136985A1 Für das gap2-Gen kodierende Nukleotidsequenzen For the gap2 gene coding nucleotide sequences |
03/21/2002 | DE10132947A1 Für das rodA-Gen kodierte Nukleotidsequenzen For the rodA gene encoded nucleotide sequences |
03/21/2002 | DE10132176A1 Neue für das fts-Gen kodierende Nukleotidsequenzen New coding for the fts gene nucleotide sequences |
03/21/2002 | DE10112430A1 Neue für das dep33-Gen kodierende Nukleotidsequenzen New coding for the dep33 gene nucleotide sequences |
03/21/2002 | DE10112429A1 Neue für das dep34-Gen kodierende Nukleotidsequenzen New coding for the dep34 gene nucleotide sequences |
03/21/2002 | DE10112105A1 Neue für das luxS-Gen kodierende Nukleotidsequenzen New coding for the luxS gene nucleotide sequences |
03/21/2002 | DE10109022A1 Neue für das chrS-Gen kodierende Nukleotidsequenzen New coding for the CHRS gene nucleotide sequences |
03/21/2002 | DE10044681A1 New L-lactate dehydrogenase gene from coryneform bacteria, useful, when overexpressed, for increasing fermentative production of L-amino acid |
03/21/2002 | CA2423559A1 22 human secreted proteins |
03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |